Toxic effects of interferon administered intrathecally
Multiple sclerosis is a neurological disease of unknown aetiology with signs of defective immunoregulation. Studies with immunologically active agents and immunosuppressive drugs have been carried out. Interferons, of which there are at least three types (cc, 3, and y), are antiviral, cytostatic, and immunomodulatory proteins. The impaired production of interferon in patients with multiple sclerosis' has prompted follow up trials of treatment with interferon in these patients.2 Since only 2-4% of interferon injected intramuscularly passes the blood-brain barrier, intrathecal administration has been used to obtain higher concentrations in the cerebrospinal fluid. Exogenous interferon-5 given intrathecally appears to be fairly nontoxic.3 We report our recent experience with intrathecal administration of interferon-ac.
Patients, methods, and results
We studied five severely disabled patients (two men, three women, mean age 34-8 years) with chronic progressive multiple sclerosis. 
